Home

Barsch Status Fallschirm nmd pharma claus olesen Unglück Immunität Insgesamt

PROPOSED DISTRIBUTION OF SANIONA AB'S SHARES IN INITIATOR PHARMA A/S TO  SHAREHOLDERS IN SANIONA AB
PROPOSED DISTRIBUTION OF SANIONA AB'S SHARES IN INITIATOR PHARMA A/S TO SHAREHOLDERS IN SANIONA AB

NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma company information, funding & investors | Dealroom.co

Initiator Pharma
Initiator Pharma

Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn

NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma company information, funding & investors | Dealroom.co

NMD Pharma - Crunchbase Company Profile & Funding
NMD Pharma - Crunchbase Company Profile & Funding

UNIVERSITY OF COPENHAGEN Project title Novel Treatments of Neuromuscular  Disease Mentor 1 Pontus Gourdon, MSc & PhD,
UNIVERSITY OF COPENHAGEN Project title Novel Treatments of Neuromuscular Disease Mentor 1 Pontus Gourdon, MSc & PhD,

Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn

Annual Report 2016 by Lundbeckfonden - issuu
Annual Report 2016 by Lundbeckfonden - issuu

Company Presentation
Company Presentation

NMD Pharma A/S | LinkedIn
NMD Pharma A/S | LinkedIn

NMD Pharma to advance neuromuscular disorder therapies with €38m Series A  round
NMD Pharma to advance neuromuscular disorder therapies with €38m Series A round

Initiator Pharma
Initiator Pharma

BioLeader Interview - PIR International
BioLeader Interview - PIR International

Company Presentation
Company Presentation

Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn

Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn

PROPOSED DISTRIBUTION OF SANIONA AB'S SHARES IN INITIATOR PHARMA A/S TO  SHAREHOLDERS IN SANIONA AB
PROPOSED DISTRIBUTION OF SANIONA AB'S SHARES IN INITIATOR PHARMA A/S TO SHAREHOLDERS IN SANIONA AB

Claus OLESEN | Aarhus University | AU | Department of Biomedicine
Claus OLESEN | Aarhus University | AU | Department of Biomedicine

Initiator Pharma
Initiator Pharma

NMD Pharma A/S | LinkedIn
NMD Pharma A/S | LinkedIn

NMD Pharma
NMD Pharma

Well-financed biotech company to enter the clinic in 2020
Well-financed biotech company to enter the clinic in 2020

Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn

Initiator Pharma | LinkedIn
Initiator Pharma | LinkedIn